Investigation for the evaluation of the cognitive functional decline by the anticancer drug in Japanese.

Investigation for the evaluation of the cognitive functional decline by the anticancer drug in Japanese. - Investigation for the evaluation of the cognitive functional decline by the anticancer drug in Japanese.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026290

Enrollment

Registered

2017-02-24

Start date

2017-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy person

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Student of Showa University school of Pharmacy 20 years or older.

Exclusion criteria

Exclusion criteria: The person who has a medical examination in psychiatry, psychosomatic medicine, cranial nerve internal medicine or either neurosurgical regularly.

Design outcomes

Primary

Measure	Time frame
Score of the Wechsler Adult Intelligence Scale-III (WAIS-III), the Mini Mental State Examination (MMSE), Trail Making Test (TMT) A and B, Controlled Oral Word Association test (COWA) and Grooved Pegboard Test (PEG).	—

Countries

Japan

Contacts

Public ContactKosuke Takata

Showa university school of pharmacy Healthcare and Regulatory Sciences

k.takata@cmed.showa-u.ac.jp03-3784-8215

Outcome results